Compare Transcat, Inc. with Similar Stocks
Dashboard
1
Poor long term growth as Net Sales has grown by an annual rate of 13.42% and Operating profit at 9.71% over the last 5 years
- INTEREST COVERAGE RATIO(Q) Lowest at 534.53
- ROCE(HY) Lowest at 2.73%
- DEBT-EQUITY RATIO (HY) Highest at 43.98 %
2
With ROCE of 4.15%, it has a very expensive valuation with a 2.00 Enterprise value to Capital Employed
3
Underperformed the market in the last 1 year
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
25.38%
0%
25.38%
6 Months
0.79%
0%
0.79%
1 Year
1.57%
0%
1.57%
2 Years
-35.4%
0%
-35.4%
3 Years
-15.92%
0%
-15.92%
4 Years
-3.96%
0%
-3.96%
5 Years
43.05%
0%
43.05%
Transcat, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
13.42%
EBIT Growth (5y)
9.71%
EBIT to Interest (avg)
12.59
Debt to EBITDA (avg)
1.13
Net Debt to Equity (avg)
0.12
Sales to Capital Employed (avg)
0.96
Tax Ratio
20.80%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
10.16%
ROE (avg)
9.47%
Valuation key factors
Factor
Value
P/E Ratio
79
Industry P/E
Price to Book Value
2.34
EV to EBIT
48.14
EV to EBITDA
19.23
EV to Capital Employed
2.00
EV to Sales
2.49
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
4.15%
ROE (Latest)
2.95%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Bearish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Mildly Bearish
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 46 Schemes (48.77%)
Foreign Institutions
Held by 65 Foreign Institutions (4.48%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY
Dec'25
Dec'24
Change(%)
Net Sales
83.90
66.80
25.60%
Operating Profit (PBDIT) excl Other Income
8.00
7.30
9.59%
Interest
1.50
0.20
650.00%
Exceptional Items
-0.80
-0.80
Consolidate Net Profit
-1.10
2.40
-145.83%
Operating Profit Margin (Excl OI)
10.80%
43.10%
-3.23%
USD in Million.
Net Sales
YoY Growth in quarter ended Dec 2025 is 25.60% vs 2.45% in Dec 2024
Consolidated Net Profit
YoY Growth in quarter ended Dec 2025 is -145.83% vs -27.27% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'25
Mar'25
Mar'24
Change(%)
Net Sales
278.40
259.50
7.28%
Operating Profit (PBDIT) excl Other Income
36.90
35.10
5.13%
Interest
0.80
1.80
-55.56%
Exceptional Items
-0.70
-1.80
61.11%
Consolidate Net Profit
14.50
13.60
6.62%
Operating Profit Margin (Excl OI)
65.90%
82.90%
-1.70%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2025 is 7.28% vs 12.53% in Mar 2024
Consolidated Net Profit
YoY Growth in year ended Mar 2025 is 6.62% vs 27.10% in Mar 2024
About Transcat, Inc. 
Transcat, Inc.
Electronics & Appliances
Transcat, Inc is a provider of calibration and laboratory instrument services and a distributor of professional grade test, measurement and control instrumentation. The Company conducts its business through two segments: service (Service) and distribution (Distribution). The Company is focused on providing its services and products to the life science industries, which include pharmaceutical, biotechnology, medical device manufacturing and other Food and Drug Administration (FDA)-regulated businesses. The Company also focuses on other industries, which include industrial manufacturing; energy and utility, including oil and gas and chemical manufacturing. The Company's subsidiaries include Transcat Canada Inc., United Scale & Engineering Corporation, WTT Real Estate Acquisition, LLC and Anmar Metrology Inc.
Company Coordinates 
Company Details
35 Vantage Point Dr , ROCHESTER NY : 14624-1142
Registrar Details






